Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Office immunotherapy in chronic inflammatoryh demyelinating polyneuropathy and multifocal motor neuropathy.
Challenging AQP4 druggability for NMO-IgG antibody binding using molecular dynamics and molecular interaction fields.
Functional limitations in functional somatic syndromes and well-defined medical diseases. Results from the general population cohort LifeLines.
Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology.
Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome.
Acute demyelinating encephalomyelitis presenting with psychiatric symptoms.
Analysis of the host transcriptome from demyelinating spinal cord of murine coronavirus-infected mice.
Antiparasitic antibodies occur with similar frequency in patients with clinically established multiple sclerosis with or without oligoclonal bands in the cerebrospinal fluid.
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage.
Perception of muscular effort during dynamic elbow extension in multiple sclerosis.
Expanding the differential diagnosis of inherited neuropathies with non-uniform conduction: Andermann syndrome.
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Changes in normal appearing spinal cord in multiple sclerosis: another brick in the wall.
Cognitive processing speed has minimal influence on the construct validity of Multiple Sclerosis Walking Scale-12 scores.
Association Between Self-Administered Expanded Disease Severity Scale (Edss) and Multiple Sclerosis Impact Scale (Msis-29): Results from The Burden of Illness In Patients With Multiple Sclerosis In Finland (Defense) Study.
Store-operated Calcium Entry into B Cells Regulates Autoimmune Inflammation.
Molecular Architecture of Myelinated Nerve Fibers: Leaky Paranodal Junctions and Paranodal Dysmyelination.
Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
Chemokines in the balance: maintenance of homeostasis and protection at CNS barriers.
Haplotype-based approach to known MS-associated regions increases the amount of explained risk.
Signs of myelin impairment in cerebrospinal fluid after osmotic opening of the blood-brain barrier in rats.
Correction: Kinetics of IL-6 Production Defines T Effector Cell Responsiveness to Regulatory T Cells in Multiple Sclerosis.
Electrodiagnostics and clinical correlates in acquired polyneuropathies.
The carbocyanine dye DiD labels in vitro and in vivo neural stem cells of the subventricular zone as well as myelinated structures following in vivo injection in the lateral ventricle.
Microglia regulate hippocampal neurogenesis during chronic neurodegeneration.
Pages
« first
‹ previous
…
629
630
631
632
633
634
635
636
637
…
next ›
last »